VOICED : OMS anuncia una vacuna contra ebola con un 100% de eficacia

The World Health Organization announced a Canadian-origin Ebola vaccine with a potential 100% efficacy. The vaccine showed no cases of Ebola among vaccinated individuals, compared to 23 cases in the unvaccinated group. The vaccine's commercialization rights were acquired by Merck, and it could be registered by 2018 after regulatory reviews. The standard approval process takes a decade, but the WHO is prepared for future Ebola outbreaks. The recent Ebola outbreak in West Africa resulted in over 11,000 deaths, overwhelming health systems and economies in countries like Guinea, Sierra Leone, and Liberia.

What was the reported efficacy rate of the Canadian-origin Ebola vaccine according to WHO?

• 90%

• 75%

• 100%

• 50%

Which company acquired the commercialization rights for the Ebola vaccine?

• Pfizer

• Merck

• Johnson & Johnson

• AstraZeneca

By what year could the Ebola vaccine potentially be registered after review?

• 2016

• 2017

• 2019

• 2018

How many people died in the recent Ebola outbreak in West Africa?

• Over 15,000

• Over 11,000

• Over 5,000

• Over 8,000

Which countries were mentioned as being severely affected by the Ebola outbreak?

• Nigeria, Ghana, and Togo

• Guinea, Sierra Leone, and Liberia

• Kenya, Uganda, and Tanzania

• South Africa, Namibia, and Botswana